Conditions: Prostate Cancer
Keywords: Androgen insensitive prostate cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 27
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether positron emission tomography / computed tomography (PET/CT) using fluorine-18 fluorocholine as an imaging agent can characterize regional responses to anti-androgen therapies in a manner that in the future aid in the customized planning of treatments for patients with androgen-insensitive prostate cancer.

Detailed description:

Arms:
arm 1: Fluorine-18 fluorocholine IV in conjunction with PET/CT imaging, up to 3 doses.

Interventions: intervention 1: IV administration of fluorine-18 fluorocholine followed by PET/CT imaging
Intervention descriptions: intervention 1: Imaging intervention performed prior to and 30-75 days post a change in anti-androgen therapy.

Protocol document: